Cited in:


This article has been cited by:

  1. 1
    P. Sandgren, B. Diedrich, Pathogen inactivation of double-dose buffy-coat platelet concentrates photochemically treated with amotosalen and UVA light: preservation of in vitro function, Vox Sanguinis, 2015, 108, 3
  2. 2
    B. Van Aelst, H. B. Feys, R. Devloo, K. Vanhoorelbeke, P. Vandekerckhove, V. Compernolle, Riboflavin and amotosalen photochemical treatments of platelet concentrates reduce thrombus formation kinetics in vitro, Vox Sanguinis, 2015, 108, 3
  3. 3
    Andrea Neisser-Svae, Jerard Seghatchian, The state of the art of removal of prion proteins in SD-FFP, by specific prion affinity chromatography and its impact on the hemostatic characteristics of the product, Transfusion and Apheresis Science, 2015,


  4. 4
    Johannes Irsch, Jerard Seghatchian, Update on pathogen inactivation treatment of plasma, with the INTERCEPT Blood System: Current state of the art of methodology, quality and clinical aspects., Transfusion and Apheresis Science, 2015,


  5. 5
    Peter Schubert, Brankica Culibrk, Simrath Karwal, Katherine Serrano, Elena Levin, Daniel Bu, Varsha Bhakta, William P. Sheffield, Raymond P. Goodrich, Dana V. Devine, Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method, Transfusion, 2015, 55, 3
  6. 6
    H. B. Feys, B. Aelst, K. Devreese, R. Devloo, J. Coene, P. Vandekerckhove, V. Compernolle, Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion, Vox Sanguinis, 2014, 106, 4